BIO-UV Group (ALTUV) Fair Value & Analysis
Industrials · FR · Market cap €18.3M
Fair value as of: Jul 11, 2026
From 25 valuation models · updated 30 days ago
Share price −1.5% over the past month.
Below-average quality, and screening another 32% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (€1.22). The favourable scenario is already priced in.
- Weak quality (33/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (€0.6630 to €1.22) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.
How to read this chart
60‑month range €1.22 – €5.94 · fair‑value band €0.6630 – €1.22 · the €1.33 price screens above the €0.9010 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.
Analysis
BIO-UV Group (ALTUV) currently trades at €1.33, while our model-based Fair Value estimate is €0.9010, implying the stock looks roughly 32.3% overvalued today. The Quality Score stands at 33/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, BIO-UV Group generated revenue of €36.9M at a net margin of 2.3%. Revenue declined 2.0% year over year. It earns a return on equity of 2.3%. Net debt stands at €11.6M. Fundamentals as of Jul 11, 2026
Our scenario range runs from €0.6630 (bear case) to €1.22 (bull case); at €1.33, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 37% below its 52-week high and 9% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -32%, ALTUV screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 25 models by family
Widest divergence: Asset-Based (€1.99) versus Dividend Discount (€0.4300). Highest evidence: Growth DCF (80).
Notify me when ALTUV reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 37 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, rest of Europe, Asia, the Middle East, the Americas, and internationally. It operates through Products, Solutions, and After-Sales divisions.
Full company description
BIO-UV Group S.A. designs, manufactures, and markets water treatment and disinfectant systems using ultraviolet, salt electrolysis, ozone, and advanced oxidation for individuals and professionals in France, rest of Europe, Asia, the Middle East, the Americas, and internationally. It operates through Products, Solutions, and After-Sales divisions. The company offers disinfection equipment and systems under the triogen, AKERON, 1001 Electrodes, and BIOSEA brands; spare parts; and commissioning services. It also provides maintenance services comprising inspection and diagnosis; cleaning and replacement of parts; calibration and adjustments; updates and upgrades; and training and technical support services. The company's products are used in residential and commercial pools, aquariums, aquaculture, industrial water, municipal and domestic water, wastewater and reuse, and ballast water applications. It exports its products. BIO-UV Group S.A. was founded in 2000 and is headquartered in Lunel, France.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
BIO-UV Group reported revenue of €35.9M in FY2025 versus €33.5M in FY2021, a compound +1.8%/yr. Reported net income was €836K in FY2025, compounding +4.9%/yr from FY2021.
ALTUV screens 32% overvalued. Compare with Veralto Corporation →
Peer Group
Pollution & Treatment Controls · 91 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Pollution & Treatment Controls median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veralto Corporation VLTO | $94.21 | $69.11 | -27% |
| Zurn Elkay Water Solutions Corporation ZWS | $47.63 | $24.92 | -48% |
| Canmax Technologies Co 300390 | ¥57.02 | ¥10.41 | -82% |
| CECO Environmental Corp CECO | $83.63 | $15.19 | -82% |
| Fujian Longking Co 600388 | ¥17.58 | ¥15.59 | -11% |
| Munters Group MTRS | kr 166.60 | kr 16.90 | -90% |
| China Conch Venture Holdings 0586 | HK$8.83 | HK$14.14 | +60% |
| Mega Union Technology Inc 6944 | 1,005 TWD | 539.58 TWD | -46% |
| MayAir Technology (China) Co 688376 | ¥96.57 | ¥18.80 | -81% |
| Shanghai Emperor of Cleaning Hi-Tech Co 603200 | ¥38.97 | ¥5.73 | -85% |
Compare BIO-UV Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is BIO-UV Group (ALTUV) overvalued or undervalued?
What is the fair value of ALTUV?
What is the quality score of ALTUV?
What is the revenue of BIO-UV Group (ALTUV)?
What is the net profit margin of ALTUV?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BIO-UV Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.